labetuzumab govitecan (IMMU-130) - Gilead
CEA ISAC - Bolt Biotherapeutics
https://jitc.bmj.com/content/13/Suppl_2/A1044
 
Rishali K Gadkari 1; Andrew Luo 2; David T Omstead 3; Chi-Ling Fu 4; Katelynn A McEachin 5; Shahid Khan 6; Robert Veneziale 7; Jason Ptacek 8; Han Kim 9; Lu Xu 10; William G Mallet 11; Karla A Henning 12; Romas A Kudirka 13; Shelley E Ackerman 14; Michael N Alonso 15; Paul Ponath 16
 
Oct 3, 2025
 
Prev Next